Item 2.02. Results of Operations and Financial Condition.
On
The information in this Item 2.02, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
The financial information set forth in this Form 8-K reflects the Company's
current preliminary net revenue estimates, is subject to the completion of its
audit process, and is subject to change. The Company's fourth quarter and full
year ended
Item 7.01. Regulation FD Disclosure.
The executive officers of
The information in this Item 7.01, including the information incorporated by reference herein from Exhibit 99.2, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release datedJanuary 9, 2023 issued byOrthoPediatrics Corp. 99.2Orthopediatrics Corp. Investor Presentation datedJanuary 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
* * * * * * - 2 -
--------------------------------------------------------------------------------
© Edgar Online, source